1. Dolasetron prophylaxis reduces nausea and postanaesthesia recovery time after remifentanil infusion during monitored anaesthesia care for extracorporeal shock wave lithotripsy† 
M.A. Burmeister, T.G. Standl, M. Wintruff, P. Brauer, I. Blanc, J. Schulte am Esch 
British Journal of Anaesthesia 
Volume 90, Issue 2, Pages (February 2003)
DOI: /bja/aeg047
Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

2. Fig 1
Percentage of patients with postoperative nausea (≤5 mm VAS), retching, vomiting, and rescue therapy with droperidol. *P<0.05 dolasetron vs placebo.
British Journal of Anaesthesia  , DOI: ( /bja/aeg047)
Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

3. Fig 2
Mean maximal intensity of nausea in both groups during ESWL and until 60 min and from 1 to 24 h postoperatively. *P<0.05 dolasetron vs placebo.
British Journal of Anaesthesia  , DOI: ( /bja/aeg047)
Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

4. Fig 3
Percentage of patients who had to stay in the PACU after the ESWL therapy because the discharge criteria were not reached. The horizontal axis represents the time of measurements since the arriving in the recovery room. *P<0.01 dolasetron vs placebo.
British Journal of Anaesthesia  , DOI: ( /bja/aeg047)
Copyright © 2003 British Journal of Anaesthesia Terms and Conditions